Four things to know:
1. The drugmakers invited to testify are Eli Lilly, Gilead, Merck, Pfizer, Mylan and Mallinckrodt.
2. The caucus hopes the invitation will place a spotlight on progressives’ views on drug-pricing.
3. The invitation is far less formal than those extended earlier this year by three other congressional committees that have called on various industry CEOs to testify.
4. The House progressives are an informal caucus, so they lack subpoena power and likely the influence to force pharma executives to attend, according to the report.
Read the full report here.
More articles on pharmacy:
Sanofi poaches exec from Novartis
Eli Lilly’s migraine drug 1st approved to reduce cluster headaches: 4 notes
EpiPen shortage will drag on: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
